Cargando…
Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study
BACKGROUND: The tolerability and efficacy of single dose albendazole (400 mg), diethylcarbamazine citrate (DEC) (6 mg/kg bodyweight) or co-administration of albendazole (400 mg) + DEC (6 mg/kg bodyweight) was studied in 54 asymptomatic Wuchereria bancrofti microfilaraemic volunteers in a double blin...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139957/ https://www.ncbi.nlm.nih.gov/pubmed/12537598 http://dx.doi.org/10.1186/1475-2883-1-1 |
_version_ | 1782120576249233408 |
---|---|
author | Pani, SP Subramanyam Reddy, G Das, LK Vanamail, P Hoti, SL Ramesh, J Das, PK |
author_facet | Pani, SP Subramanyam Reddy, G Das, LK Vanamail, P Hoti, SL Ramesh, J Das, PK |
author_sort | Pani, SP |
collection | PubMed |
description | BACKGROUND: The tolerability and efficacy of single dose albendazole (400 mg), diethylcarbamazine citrate (DEC) (6 mg/kg bodyweight) or co-administration of albendazole (400 mg) + DEC (6 mg/kg bodyweight) was studied in 54 asymptomatic Wuchereria bancrofti microfilaraemic volunteers in a double blind hospital-based clinical study. RESULTS: There was no significant difference in the overall incidence of adverse reactions between the three drug groups [42.1% (albendazole), 52.9% (DEC) and 61.1% (albendazole + DEC); P > 0.05]. The mean score of adverse reaction intensity did not differ significantly between the DEC and albendazole + DEC groups. However, the values in these two groups were significantly higher compared to that of albendazole alone [1.8 ± 3.0 (albendazole) vs. 5.6 ± 7.1 (DEC), 6.7 ± 6.6 (albendazole + DEC); P < 0.05]. By day 360 post-therapy there was no significant difference between the three drug groups in relation to the clearance of microfilaria [26.3% (albendazole), 17.6% (DEC), 27.8% (albendazole + DEC)], reduction in geometric mean parasite density [94.7% (albendazole), 89.5% (DEC), 95.4% (albendazole + DEC)] or reduction in filarial antigenaemia [83% (albendazole), 87% (DEC), 75% (albendazole + DEC)]. Furthermore, there was a significant decrease in mean geometric parasite density (P < 0.05) as well as antigenaemia optical density values (P < 0.01) between pre-therapy levels and day 360 post-therapy in all three groups. CONCLUSIONS: This study has shown that single dose albendazole (400 mg) has similar efficacy in the clearance of microfilaria as that of DEC or the co-administration of the two drugs. The results strengthen the rationale of using albendazole for mass annual single dose administration for the control of transmission of lymphatic filariasis. |
format | Text |
id | pubmed-139957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-1399572003-01-20 Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study Pani, SP Subramanyam Reddy, G Das, LK Vanamail, P Hoti, SL Ramesh, J Das, PK Filaria J Research BACKGROUND: The tolerability and efficacy of single dose albendazole (400 mg), diethylcarbamazine citrate (DEC) (6 mg/kg bodyweight) or co-administration of albendazole (400 mg) + DEC (6 mg/kg bodyweight) was studied in 54 asymptomatic Wuchereria bancrofti microfilaraemic volunteers in a double blind hospital-based clinical study. RESULTS: There was no significant difference in the overall incidence of adverse reactions between the three drug groups [42.1% (albendazole), 52.9% (DEC) and 61.1% (albendazole + DEC); P > 0.05]. The mean score of adverse reaction intensity did not differ significantly between the DEC and albendazole + DEC groups. However, the values in these two groups were significantly higher compared to that of albendazole alone [1.8 ± 3.0 (albendazole) vs. 5.6 ± 7.1 (DEC), 6.7 ± 6.6 (albendazole + DEC); P < 0.05]. By day 360 post-therapy there was no significant difference between the three drug groups in relation to the clearance of microfilaria [26.3% (albendazole), 17.6% (DEC), 27.8% (albendazole + DEC)], reduction in geometric mean parasite density [94.7% (albendazole), 89.5% (DEC), 95.4% (albendazole + DEC)] or reduction in filarial antigenaemia [83% (albendazole), 87% (DEC), 75% (albendazole + DEC)]. Furthermore, there was a significant decrease in mean geometric parasite density (P < 0.05) as well as antigenaemia optical density values (P < 0.01) between pre-therapy levels and day 360 post-therapy in all three groups. CONCLUSIONS: This study has shown that single dose albendazole (400 mg) has similar efficacy in the clearance of microfilaria as that of DEC or the co-administration of the two drugs. The results strengthen the rationale of using albendazole for mass annual single dose administration for the control of transmission of lymphatic filariasis. BioMed Central 2002-10-10 /pmc/articles/PMC139957/ /pubmed/12537598 http://dx.doi.org/10.1186/1475-2883-1-1 Text en Copyright © 2002 Pani et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
spellingShingle | Research Pani, SP Subramanyam Reddy, G Das, LK Vanamail, P Hoti, SL Ramesh, J Das, PK Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study |
title | Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study |
title_full | Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study |
title_fullStr | Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study |
title_full_unstemmed | Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study |
title_short | Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study |
title_sort | tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (dec) or co-administration of albendazole with dec in the clearance of wuchereria bancrofti in asymptomatic microfilaraemic volunteers in pondicherry, south india: a hospital-based study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139957/ https://www.ncbi.nlm.nih.gov/pubmed/12537598 http://dx.doi.org/10.1186/1475-2883-1-1 |
work_keys_str_mv | AT panisp tolerabilityandefficacyofsingledosealbendazolediethylcarbamazinecitratedecorcoadministrationofalbendazolewithdecintheclearanceofwuchereriabancroftiinasymptomaticmicrofilaraemicvolunteersinpondicherrysouthindiaahospitalbasedstudy AT subramanyamreddyg tolerabilityandefficacyofsingledosealbendazolediethylcarbamazinecitratedecorcoadministrationofalbendazolewithdecintheclearanceofwuchereriabancroftiinasymptomaticmicrofilaraemicvolunteersinpondicherrysouthindiaahospitalbasedstudy AT daslk tolerabilityandefficacyofsingledosealbendazolediethylcarbamazinecitratedecorcoadministrationofalbendazolewithdecintheclearanceofwuchereriabancroftiinasymptomaticmicrofilaraemicvolunteersinpondicherrysouthindiaahospitalbasedstudy AT vanamailp tolerabilityandefficacyofsingledosealbendazolediethylcarbamazinecitratedecorcoadministrationofalbendazolewithdecintheclearanceofwuchereriabancroftiinasymptomaticmicrofilaraemicvolunteersinpondicherrysouthindiaahospitalbasedstudy AT hotisl tolerabilityandefficacyofsingledosealbendazolediethylcarbamazinecitratedecorcoadministrationofalbendazolewithdecintheclearanceofwuchereriabancroftiinasymptomaticmicrofilaraemicvolunteersinpondicherrysouthindiaahospitalbasedstudy AT rameshj tolerabilityandefficacyofsingledosealbendazolediethylcarbamazinecitratedecorcoadministrationofalbendazolewithdecintheclearanceofwuchereriabancroftiinasymptomaticmicrofilaraemicvolunteersinpondicherrysouthindiaahospitalbasedstudy AT daspk tolerabilityandefficacyofsingledosealbendazolediethylcarbamazinecitratedecorcoadministrationofalbendazolewithdecintheclearanceofwuchereriabancroftiinasymptomaticmicrofilaraemicvolunteersinpondicherrysouthindiaahospitalbasedstudy |